Should all patients with pulmonary hypertension undergo HIV serologic testing?

Southern Medical Journal

Volumn 104, Issue 8, 2011, Pages 589-592

  Vazquez, Alexis A ^a   Aduen, Javier F ^a   Aduen, Paula ^a   Heckman, Michael G ^a   Burger, Charles D ^a  

^a MAYO CLINIC   (United States)

Author keywords

HIV; HIV screening; human immunodeficiency virus; pulmonary hypertension

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; AGED; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SCREENING TEST; VIRUS DIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HIV ANTIBODIES; HIV SEROPOSITIVITY; HUMANS; HYPERTENSION, PULMONARY; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEROLOGIC TESTS; YOUNG ADULT;

EID: 80051528120     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318225cdfd     Document Type: Review

References (12)

1. Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vas-culopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43: 25S-32S. (Pubitemid 38759714)
2. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-S54.
3. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:14S-34S. (Pubitemid 38932340)
4. McLaughlin VV, Archer SL, Badesch DB, et al, American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53:1573-1619.
5. Opravil M, Pechere M, Speich R, et al. HIV-associated primary pulmonary hypertension: a case control study: Swiss HIV Cohort Study. Am J Respir Crit Care Med 1997;155:990-995. (Pubitemid 27133414)
6. Mehta NJ, Khan IA, Mehta RN, et al. HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 2000;118:1133-1141.
7. Zuber JP, Calmy A, Evison JM, et al. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004;38:1178-1185. (Pubitemid 38951268)
8. Sitbon O, Lascoux-Combe C, Delfraissy JF, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era [published online ahead of print October 11, 2007]. Am J Respir Crit Care Med 2008;177:108-113.
9. Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126: 7S-10S. (Pubitemid 38932338)
10. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173:1023-1030.
11. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry [published online ahead of print October 16, 2009]. Chest 2010;137: 376-387.
12. Humbert M, McLaughlin VV. The 4th World Symposium on Pulmonary Hypertension: introduction. J Am Coll Cardiol 2009;54:S1-S2.